Patents

In accordance with the notice provisions of Section 287(a) of Title 35 of the United States Code, the following U.S. patents are associated with YUPELRI™ (revefenacin) inhalation solution:

U.S. Patent No. 7,288,657;
U.S. Patent No. 7,491,736;
U.S. Patent No. 7,521,041;
U.S. Patent No. 7,550,595;
U.S. Patent No. 7,585,879;
U.S. Patent No. 7,910,608;
U.S. Patent No. 8,034,946;
U.S. Patent No. 8,053,448;
U.S. Patent No. 8,273,894; and
U.S. Patent No. 10,106,503

I%20thought%20this%20might%20interest%20you-%20FDA%20Approved%20YUPELRI™%20(revefenacin)%20inhalation%20solution
YUPELRI%20%28revefenacin%29%20inhalation%20solution%20is%20now%20FDA%20Approved%E2%80%94Learn%20more%20at%20YUPELRI.com.%0A%0ASee%20the%20full%20Prescribing%20Information%20and%20Medication%20Guide.%0A%0AFor%20additional%20information%20please%20contact%20us%20800-395-3376.%0A